Mar 04 2021 Read 417 Times
Aalto Bio Reagents is delighted to announce the re-launch of their world renowned affinity-purified anti-HIV-1 gp120 antibody, code D7324, for research use globally. Aalto Bio Reagents has been supplying HIV reagents to the research community since 1988 and there are now over 100 international cited publications referencing use of our HIV-1 gp120. Produced by immunising sheep with the gp120 protein sequence of the BH-10 strain, this antibody targets the most dominant subtype of HIV-1 seen in the Americas, Western Europe and Australasia - subtype B.
Since the first reported cases in 1981, HIV continues to be a major public health issue with over 38 million people living with the infection worldwide, 7 million of whom are unaware they have the infection. Although there are successful treatments now available for managing HIV, there are still consistently large numbers of people becoming newly infected, with almost 2 million adults and over 150,000 childr
(2)
Microturbines to be Deployed at a Gathering Station in India for Flare Recovery Project
VAN NUYS, CA / ACCESSWIRE / March 4, 2021 / Capstone Turbine Corporation (www.capstoneturbine.com) (NASDAQ:CPST), the world s leading manufacturer of clean technology microturbine energy systems, announced today that it received a follow-on order for Oil and Natural Gas Corporation (ONGC), India s renowned multi-national oil and gas company, for one C200 Signature Series and two C65 microturbines. Brio Energy Pvt. Ltd., Capstone s exclusive distributor in India (www.brioenergy.in), secured the order, which is expected to be commissioned in May 2021.
Capstone continues its growth in the South Asian oil and gas market with its recent follow-on order from ONGC. The microturbines, destined for a remote gathering station in western India, will provide primary power to the facility while simultaneously reducing the flaring of associated gas which negatively impacts the environment. Utilizing the
Coastal Arts Trail plan to draw crowds to Whanganui
4 Mar, 2021 04:00 PM
6 minutes to read
Galleries along the west coast will feature in the new campaign. Photo / Lewis Gardner
Mike Tweed is a multimedia journalist at the Whanganui Chroniclemichael.tweed@nzme.co.nzWhangaChron
Whanganui s reputation as an arts destination is set to get a major boost when a comprehensive plan to draw more tourists to the region is fully unveiled in the next few weeks. The Coastal Arts Trail, a new, multi-regional itinerary of art galleries, museums and open studios in Whanganui, Taranaki and Manawatū, is a collaboration between economic development agency Whanganui & Partners, Venture Taranaki and CEDA (Central Economic Development Agency).
(1)
BERLIN and ZUG, Switzerland, March 04, 2021 (GLOBE NEWSWIRE) BERLIN HEALS, a company dedicated to developing and offering novel and life-saving treatments for patients suffering from heart failure, announces results of a first-in-human study published in
ESC Heart Failure, in patients with dilated cardiomyopathy for its proprietary C-MIC device. The C-MIC is a small implantable device that delivers a minimal constant electrical DC current to the heart. The results show significant, rapid improvements in heart function, heart size and quality of life of patients. Thus, this treatment has the potential to become the first sustainable, almost curative, treatment for heart failure in patients with unmet medical needs.